These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 36579068)

  • 1. Societal preferences for funding orphan drugs in China: An application of the discrete choice experiment method.
    Tan S; Wang Y; Tang Y; Jiang R; Chen M; Chen H; Yang F
    Front Public Health; 2022; 10():1005453. PubMed ID: 36579068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Societal Preferences for Funding Orphan Drugs in the United Kingdom: An Application of Person Trade-Off and Discrete Choice Experiment Methods.
    Bourke SM; Plumpton CO; Hughes DA
    Value Health; 2018 May; 21(5):538-546. PubMed ID: 29753350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Valuation of Treatments for Rare Diseases: A Systematic Literature Review of Societal Preference Studies.
    Dabbous O; Chachoua L; Aballéa S; Sivignon M; Persson U; Petrou S; Richardson J; Simoens S; Toumi M
    Adv Ther; 2023 Feb; 40(2):393-424. PubMed ID: 36451072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using a stated preference discrete choice experiment to assess societal value from the perspective of decision-makers in Europe. Does it work for rare diseases?
    López-Bastida J; Ramos-Goñi JM; Aranda-Reneo I; Trapero-Bertran M; Kanavos P; Rodriguez Martin B
    Health Policy; 2019 Feb; 123(2):152-158. PubMed ID: 30528244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Social Preferences for Orphan Drugs: A Discrete Choice Experiment Among the French General Population.
    Toumi M; Millier A; Cristeau O; Thokagevistk-Desroziers K; Dorey J; Aballéa S
    Front Med (Lausanne); 2020; 7():323. PubMed ID: 32766260
    [No Abstract]   [Full Text] [Related]  

  • 6. Quantifying stakeholders' preference for implantable medical devices in China: a discrete choice experiment.
    Wan B; Shen J; Chen J; Weng L; Zhao P; Deng Y; Zhang L; Zhang F; Wang Y; Li X; Chang F; Ding H; Lu Y
    Int J Technol Assess Health Care; 2024 Jan; 40(1):e8. PubMed ID: 38221900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing Preferences for Disease Profiles: A Discrete Choice Experiment from a US Societal Perspective.
    Johnston KM; Audhya IF; Dunne J; Feeny D; Neumann P; Malone DC; Szabo SM; Gooch KL
    Appl Health Econ Health Policy; 2024 May; 22(3):343-352. PubMed ID: 38253973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. QALY-type preference and willingness-to-pay among end-of-life patients with cancer treatments: a pilot study using discrete choice experiment.
    Yin Y; Peng Q; Ma L; Dong Y; Sun Y; Xu S; Ding N; Liu X; Zhao M; Tang Y; Mei Z; Shao H; Yan D; Tang W
    Qual Life Res; 2024 Mar; 33(3):753-765. PubMed ID: 38079024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A discrete choice experiment investigating preferences for funding drugs used to treat orphan diseases: an exploratory study.
    Mentzakis E; Stefanowska P; Hurley J
    Health Econ Policy Law; 2011 Jul; 6(3):405-33. PubMed ID: 21205401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigating patients' preferences for new anti-diabetic drugs to inform public health insurance coverage decisions: a discrete choice experiment in China.
    Geng J; Bao H; Feng Z; Meng J; Yu X; Yu H
    BMC Public Health; 2022 Oct; 22(1):1860. PubMed ID: 36199056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How Do People with Experience of Infertility Value Different Aspects of Assistive Reproductive Therapy? Results from a Multi-Country Discrete Choice Experiment.
    Skedgel C; Ralphs E; Finn E; Markert M; Samuelsen C; Whitty JA
    Patient; 2022 Jul; 15(4):459-472. PubMed ID: 34940935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient versus physician preferences for lipid-lowering drug therapy: A discrete choice experiment.
    Zhang L; Chen J; Cao Z; Zhang M; Ma R; Zhang P; Yao G; Li X
    Health Expect; 2024 Apr; 27(2):e14043. PubMed ID: 38590082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Societal preferences for rheumatoid arthritis treatments: evidence from a discrete choice experiment.
    Harrison M; Marra C; Shojania K; Bansback N
    Rheumatology (Oxford); 2015 Oct; 54(10):1816-25. PubMed ID: 25989956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Payer Preferences and Willingness to Pay for Genomic Precision Medicine: A Discrete Choice Experiment.
    Dhanda DS; Veenstra DL; Regier DA; Basu A; Carlson JJ
    J Manag Care Spec Pharm; 2020 Apr; 26(4):529-537. PubMed ID: 32223606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using a discrete choice experiment to elicit time trade-off and willingness-to-pay amounts for influenza health-related quality of life at different ages.
    Prosser LA; Payne K; Rusinak D; Shi P; Messonnier M
    Pharmacoeconomics; 2013 Apr; 31(4):305-15. PubMed ID: 23512145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient Preferences for Attributes that Characterise Alternative Models of Care in Gastroenterology: A Discrete Choice Experiment.
    Mutsekwa RN; Campbell KL; Canavan R; Mulhern B; Angus RL; Byrnes JM
    Patient; 2023 Mar; 16(2):165-177. PubMed ID: 36637751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attribute nonattendance in COVID-19 vaccine choice: A discrete choice experiment based on Chinese public preference.
    Xiao J; Wang F; Wang M; Ma Z
    Health Expect; 2022 Jun; 25(3):959-970. PubMed ID: 35049117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Women's preferences for attributes of first-trimester miscarriage management: a stated preference discrete-choice experiment.
    Petrou S; McIntosh E
    Value Health; 2009 Jun; 12(4):551-9. PubMed ID: 18798807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding influencing attributes of COVID-19 vaccine preference and willingness-to-pay among Chinese and American middle-aged and elderly adults: A discrete choice experiment and propensity score matching study.
    Li X; Yang L; Tian G; Feng B; Jia X; He Z; Liu T; Zhao X; Huang M; Yu W; Yu L; Ming WK
    Front Public Health; 2023; 11():1067218. PubMed ID: 37006586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Study of Patient Preferences for the Treatment of Non-small Cell Lung Cancer in Western China: A Discrete-Choice Experiment.
    Liu F; Hu H; Wang J; Chen Y; Hui S; Hu M
    Front Public Health; 2021; 9():653450. PubMed ID: 33842426
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.